Targeting HDAC9 Contributes to Degradation of MLL Fusion Oncoproteins in KMT2A-Rearranged Acute Myeloid Leukemia

被引：0
|
作者：
Zhou, Yutong [1 ]
Qian, Yu [1 ]
Jin, Jie [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Fusion and flow: refining risk prediction in KMT2A-rearranged pediatric acute myeloid leukemia
    Conneely, Shannon E.
    Rau, Rachel E.
    TRANSLATIONAL PEDIATRICS, 2023, 12 (12) : 2099 - 2102
  • [2] Decoding the Epigenetic Drivers of Menin-MLL Inhibitor Resistance in KMT2A-Rearranged Acute Myeloid Leukemia
    Zhou, Xinyue
    Zhang, Lixia
    Aryal, Sajesan
    Moreira, Steven
    Veasey, Virginia
    Hope, Kristin J.
    Lu, Rui
    BLOOD, 2023, 142
  • [3] KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia
    Takuyo Kanayama
    Toshihiko Imamura
    Yasuhiro Kawabe
    Shinya Osone
    Junko Tahara
    Fuminori Iwasaki
    Naoyuki Miyagawa
    Hiroaki Goto
    Shinsaku Imashuku
    Hajime Hosoi
    International Journal of Hematology, 2018, 108 : 665 - 669
  • [4] KMT2A-rearranged infantile acute myeloid leukemia masquerading as juvenile myelomonocytic leukemia
    Kanayama, Takuyo
    Imamura, Toshihiko
    Kawabe, Yasuhiro
    Osone, Shinya
    Tahara, Junko
    Iwasaki, Fuminori
    Miyagawa, Naoyuki
    Goto, Hiroaki
    Imashuku, Shinsaku
    Hosoi, Hajime
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (06) : 665 - 669
  • [5] UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia
    Xinyue Zhou
    Pengcheng Zhang
    Sajesan Aryal
    Lixia Zhang
    Rui Lu
    Leukemia, 2023, 37 : 226 - 230
  • [6] Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia
    Vetro, Calogero
    Haferlach, Torsten
    Meggendorfer, Manja
    Stengel, Anna
    Jeromin, Sabine
    Kern, Wolfgang
    Haferlach, Claudia
    CANCER GENETICS, 2020, 240 : 15 - 22
  • [7] UTX loss alters therapeutic responses in KMT2A-rearranged acute myeloid leukemia
    Zhou, Xinyue
    Zhang, Pengcheng
    Aryal, Sajesan
    Zhang, Lixia
    Lu, Rui
    LEUKEMIA, 2023, 37 (01) : 226 - 230
  • [8] NOVEL COMPOUNDS SYNERGIZE WITH VENETOCLAX TO TARGET KMT2A-REARRANGED ACUTE MYELOID LEUKEMIA
    Tregnago, C.
    Benetton, M.
    Da Ros, A.
    Borella, G.
    Longo, G.
    Polato, K.
    Francescato, S.
    Biffi, A.
    Pigazzi, M.
    HAEMATOLOGICA, 2022, 107 : 67 - 68
  • [9] Identification of Novel Cell Surface Therapeutic Targets for KMT2A-Rearranged Acute Myeloid Leukemia
    Theret, Louis
    Bordeleau, Marie-Eve
    Hajmirza, Azadeh
    Metois, Arnaud
    Moujaber, Ossama
    Audemard, Eric
    Spinella, Jean-Francois
    Chagraoui, Jalila
    Aubert, Leo
    Farah, Azer
    Lisi, Veronique
    Bonneil, Eric
    Boivin, Isabel
    Mayotte, Nadine
    MacRae, Tara
    Thibault, Pierre
    Lemieux, Sebastien
    Lavallee, Vincent-Philippe
    Hebert, Josee
    Sauvageau, Guy
    Roux, Philippe P.
    BLOOD, 2022, 140 : 6316 - 6317
  • [10] Selective inhibition of HDAC class IIA as therapeutic intervention for KMT2A-rearranged acute lymphoblastic leukemia
    Verbeek, Tamara C. A. I.
    Vrenken, Kirsten S.
    Arentsen-Peters, Susan T. C. J. M.
    Castro, Patricia Garrido
    van de Ven, Marieke
    van Tellingen, Olaf
    Pieters, Rob
    Stam, Ronald W.
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
12345